| pubmed-article:18809463 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18809463 | lifeskim:mentions | umls-concept:C2349001 | lld:lifeskim |
| pubmed-article:18809463 | lifeskim:mentions | umls-concept:C0681850 | lld:lifeskim |
| pubmed-article:18809463 | lifeskim:mentions | umls-concept:C1706203 | lld:lifeskim |
| pubmed-article:18809463 | lifeskim:mentions | umls-concept:C2697811 | lld:lifeskim |
| pubmed-article:18809463 | lifeskim:mentions | umls-concept:C1882598 | lld:lifeskim |
| pubmed-article:18809463 | lifeskim:mentions | umls-concept:C0000975 | lld:lifeskim |
| pubmed-article:18809463 | lifeskim:mentions | umls-concept:C1550501 | lld:lifeskim |
| pubmed-article:18809463 | lifeskim:mentions | umls-concept:C1519355 | lld:lifeskim |
| pubmed-article:18809463 | lifeskim:mentions | umls-concept:C0243264 | lld:lifeskim |
| pubmed-article:18809463 | lifeskim:mentions | umls-concept:C0815279 | lld:lifeskim |
| pubmed-article:18809463 | pubmed:issue | 2-3 | lld:pubmed |
| pubmed-article:18809463 | pubmed:dateCreated | 2009-1-28 | lld:pubmed |
| pubmed-article:18809463 | pubmed:abstractText | Hydroxytyrosol (HT) and hydroxytyrosol acetate (HT-AC) are two well-known phenolic compounds with antioxidant properties that are present in virgin olive oil (VOO). Because VOO has shown neuroprotective effects in rats, the purpose of the present study was to investigate the possible neuroprotective effect of HT and HT-AC in a model of hypoxia-reoxygenation in rat brain slices after in vitro incubation of these compounds or after 7 days of oral treatment with 5 or 10 mg/kg per day. Lactate dehydrogenase (LDH) efflux to the incubation medium was measured as a marker of brain cell death. HT and HT-AC inhibited LDH efflux in a concentration-dependent manner, with 50% inhibitory concentrations of 77.78 and 28.18 microM, respectively. Other well-known antioxidants such as vitamin E and N-acetyl-cysteine had no neuroprotective effect in this experimental model. After 1 week of treatment, HT (5 and 10 mg/kg per day p.o.) reduced LDH efflux by 37.8% and 52.7%, respectively, and HT-AC reduced LDH efflux by 45.4% and 67.8%. These data are additional evidence of the cytoprotective effect of VOO administration, and provide a preliminary basis for further study of these polyphenols as potential neuroprotective compounds. | lld:pubmed |
| pubmed-article:18809463 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18809463 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18809463 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18809463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18809463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18809463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18809463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18809463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18809463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18809463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18809463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18809463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18809463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18809463 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18809463 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:18809463 | pubmed:issn | 0304-3940 | lld:pubmed |
| pubmed-article:18809463 | pubmed:author | pubmed-author:EsparteroJosé... | lld:pubmed |
| pubmed-article:18809463 | pubmed:author | pubmed-author:De La... | lld:pubmed |
| pubmed-article:18809463 | pubmed:author | pubmed-author:González-Corr... | lld:pubmed |
| pubmed-article:18809463 | pubmed:author | pubmed-author:TrujilloMaria... | lld:pubmed |
| pubmed-article:18809463 | pubmed:author | pubmed-author:NavasMaría... | lld:pubmed |
| pubmed-article:18809463 | pubmed:author | pubmed-author:Lopez-Villodr... | lld:pubmed |
| pubmed-article:18809463 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18809463 | pubmed:day | 3 | lld:pubmed |
| pubmed-article:18809463 | pubmed:volume | 446 | lld:pubmed |
| pubmed-article:18809463 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18809463 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18809463 | pubmed:pagination | 143-6 | lld:pubmed |
| pubmed-article:18809463 | pubmed:meshHeading | pubmed-meshheading:18809463... | lld:pubmed |
| pubmed-article:18809463 | pubmed:meshHeading | pubmed-meshheading:18809463... | lld:pubmed |
| pubmed-article:18809463 | pubmed:meshHeading | pubmed-meshheading:18809463... | lld:pubmed |
| pubmed-article:18809463 | pubmed:meshHeading | pubmed-meshheading:18809463... | lld:pubmed |
| pubmed-article:18809463 | pubmed:meshHeading | pubmed-meshheading:18809463... | lld:pubmed |
| pubmed-article:18809463 | pubmed:meshHeading | pubmed-meshheading:18809463... | lld:pubmed |
| pubmed-article:18809463 | pubmed:meshHeading | pubmed-meshheading:18809463... | lld:pubmed |
| pubmed-article:18809463 | pubmed:meshHeading | pubmed-meshheading:18809463... | lld:pubmed |
| pubmed-article:18809463 | pubmed:meshHeading | pubmed-meshheading:18809463... | lld:pubmed |
| pubmed-article:18809463 | pubmed:meshHeading | pubmed-meshheading:18809463... | lld:pubmed |
| pubmed-article:18809463 | pubmed:meshHeading | pubmed-meshheading:18809463... | lld:pubmed |
| pubmed-article:18809463 | pubmed:meshHeading | pubmed-meshheading:18809463... | lld:pubmed |
| pubmed-article:18809463 | pubmed:meshHeading | pubmed-meshheading:18809463... | lld:pubmed |
| pubmed-article:18809463 | pubmed:meshHeading | pubmed-meshheading:18809463... | lld:pubmed |
| pubmed-article:18809463 | pubmed:meshHeading | pubmed-meshheading:18809463... | lld:pubmed |
| pubmed-article:18809463 | pubmed:meshHeading | pubmed-meshheading:18809463... | lld:pubmed |
| pubmed-article:18809463 | pubmed:meshHeading | pubmed-meshheading:18809463... | lld:pubmed |
| pubmed-article:18809463 | pubmed:meshHeading | pubmed-meshheading:18809463... | lld:pubmed |
| pubmed-article:18809463 | pubmed:meshHeading | pubmed-meshheading:18809463... | lld:pubmed |
| pubmed-article:18809463 | pubmed:meshHeading | pubmed-meshheading:18809463... | lld:pubmed |
| pubmed-article:18809463 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18809463 | pubmed:articleTitle | Neuroprotective effect of hydroxytyrosol and hydroxytyrosol acetate in rat brain slices subjected to hypoxia-reoxygenation. | lld:pubmed |
| pubmed-article:18809463 | pubmed:affiliation | Laboratorio de Investigaciones Antitrombóticas e Isquemia Tisular (LIAIT), Department of Pharmacology, School of Medicine, University of Malaga, Campus de Teatinos s/n, 29071 Malaga, Spain. | lld:pubmed |
| pubmed-article:18809463 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18809463 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18809463 | lld:pubmed |
